Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1487320

CC(C)(/N=N/C(C)(C)C(=N)NCCO)C(=N)NCCO.Cl.Cl

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.39
CYP3A4 P08684 1/20 0.39
MAPT P10636 1/20 0.39
CYP2D6 P10635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4207271 1.00 ALDH1A1 (0.39) ALDH1A1CYP3A4MAPTCYP2D6
Hydrochloric Acid SCHEMBL306250 1.00 ALDH1A1 (0.39) ALDH1A1CYP3A4MAPTCYP2D6
SCHEMBL3864537 0.98 ALDH1A1 (0.36) ALDH1A1CYP3A4MAPTCYP2D6
SCHEMBL3864539 0.98 ALDH1A1 (0.36) ALDH1A1CYP3A4MAPTCYP2D6
Water SCHEMBL30525491 0.96 ALDH1A1 (0.34) ALDH1A1CYP3A4MAPTCYP2D6
Water SCHEMBL31024411 0.96 ALDH1A1 (0.34) ALDH1A1CYP3A4MAPTCYP2D6
Hydrochloric Acid SCHEMBL10782209 0.83 ALDH1A1 (0.39) ALDH1A1CYP3A4MAPTCYP2D6
Hydrochloric Acid SCHEMBL10782216 0.83 ALDH1A1 (0.39) ALDH1A1CYP3A4MAPTCYP2D6
SCHEMBL5354801 0.82
Hydrochloric Acid SCHEMBL10784283 0.79 GRIN2D (0.37) ALDH1A1CYP3A4MAPTCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0767212-B1 PROCESS FOR PRODUCING AN AQUEOUS SOLUTION OF PHOSPHORYLCHOLINE GROUP BEARING POLYMER AND AQUEOUS SOLUTION OF PHOSPHORYLCHOLINE GROUP BEARING POLYMER NOF CORP (JP) 2001-07-18 EP claimed
EP-0767212-A1 PROCESS FOR PRODUCING AN AQUEOUS SOLUTION OF PHOSPHORYLCHOLINE GROUP BEARING POLYMER AND AQUEOUS SOLUTION OF PHOSPHORYLCHOLINE GROUP BEARING POLYMER Japan Science and Technology Corporation (JP) 1997-04-09 EP claimed
US-12577432-B2 Organosilicon compound, production method therefor, and curable composition SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-03-17 US disclosed
EP-4282653-B1 ORGANOSILICON COMPOUND, PRODUCTION METHOD THEREFOR, AND CURABLE COMPOSITION SHINETSU CHEMICAL CO (JP) 2026-02-25 EP disclosed
US-12522684-B2 Active-energy-ray-curable resin composition and cured product thereof NIPPON SHOKUBAI CO., LTD. (JP) 2026-01-13 US disclosed
EP-4159779-B1 ACTIVE-ENERGY-RAY-CURABLE RESIN COMPOSITION AND CURED PRODUCT THEREOF NIPPON CATALYTIC CHEM IND (JP) 2025-12-10 EP disclosed
EP-3296327-B1 METHOD FOR PRODUCING ELLIPTICAL, NEEDLE-SHAPED, OR ROD-SHAPED POLYMER PARTICLES NISSHINBO HOLDINGS INC (JP) 2024-05-15 EP disclosed
US-20240101723-A1 METHOD FOR PRODUCING MODIFIED CONJUGATED DIENE POLYMER LATEX ZEON CORPORATION (JP) 2024-03-28 US disclosed
US-20240059929-A1 ORGANOSILICON COMPOUND, PRODUCTION METHOD THEREFOR, AND CURABLE COMPOSITION SHIN-ETSU CHEMICAL CO., LTD. (JP) 2024-02-22 US disclosed
EP-4299272-A1 METHOD FOR PRODUCING MODIFIED CONJUGATED DIENE POLYMER LATEX Zeon Corporation (JP) 2024-01-03 EP disclosed
WO-2023238925-A1 RADICAL POLYMERIZABLE COMPOSITION AND POLYMERIZED PRODUCT THEREOF 株式会社日本触媒 2023-12-14 WO disclosed
US-6162563-A Polymer Solid Electrolyte DAISO CO., LTD (JP) 2000-12-19 US disclosed
US-6100305-A INCREASING ABSORPTION BY CRUSHING AND DRYING A CROSSLINKED HYDROGEL POLYMER; USING IN DIAPERS, SANITARY NAPKINS, WOUND HEALING MATERIAL; BUILDING MATERIAL AND SOIL, WATERPROOFING MATERIAL, PACKING MATERIAL NIPPON SHOKUBAI CO., LTD. (JP) 2000-08-08 US disclosed
EP-0876888-A1 METHOD OF PRODUCTION OF WATER-ABSORBING RESIN Nippon Shokubai Co., Ltd. (JP) 1998-11-11 EP disclosed
EP-0856538-A1 SOLID POLYELECTROLYTE DAISO CO., LTD. (JP) 1998-08-05 EP disclosed
EP-0767212-A1 PROCESS FOR PRODUCING AN AQUEOUS SOLUTION OF PHOSPHORYLCHOLINE GROUP BEARING POLYMER AND AQUEOUS SOLUTION OF PHOSPHORYLCHOLINE GROUP BEARING POLYMER Japan Science and Technology Corporation (JP) 1997-04-09 EP disclosed
EP-0723967-A1 Organometallic compounds and polymers made therefrom ELF ATOCHEM NORTH AMERICA, INC. (US) 1996-07-31 EP disclosed
EP-0629225-A1 ADDITIVES FOR ELECTRODEPOSITABLE COATING COMPOSITIONS PPG INDUSTRIES, INC. (US) 1994-12-21 EP disclosed
US-5260354-A Additives for electrodepositable coating compositions PPG INDUSTRIES, INC. (US) 1993-11-09 US disclosed
WO-1993018099-A1 ADDITIVES FOR ELECTRODEPOSITABLE COATING COMPOSITIONS PPG INDUSTRIES, INC. (US) 1993-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12577432-B2 Organosilicon compound, production method therefor, and curable composition ASH2L, DOT1L, DNMT3L ALDH1A1 726/4885CYP3A4 423/4885MAPT 3072/4885
US-20240059929-A1 ORGANOSILICON COMPOUND, PRODUCTION METHOD THEREFOR, AND CURABLE COMPOSITION CYP51A1, CYP4F11, FAR1 ALDH1A1 254/4885CYP3A4 72/4885MAPT 3871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.